Back
Top 0.2%
17.6%
#1
14.5%
Top 0.2%
8.9%
Top 0.5%
8.9%
Top 1%
6.4%
Top 0.7%
6.4%
Top 23%
5.0%
Top 67%
3.8%
Top 5%
3.0%
Top 89%
3.0%
Top 2%
3.0%
Top 0.6%
1.9%
#1
1.9%
Top 39%
1.2%
Top 2%
0.9%
Top 3%
0.9%
Top 20%
0.7%
Top 0.5%
0.7%
Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16
2025-09-12
respiratory medicine
Title + abstract only
View on medRxiv
Show abstract
Prior studies testing biomarkers of residual lung abnormalities after COVID-19 are limited by sampling within the first year after acute COVID-19 illness and lack of external validation of findings. In three independent, international, racially and ethnically diverse prospective cohorts of survivors of moderate to critical COVID-19, we systematically tested 18 circulating biomarkers of inflammation, aging, endothelial activation, pulmonary epithelial function, fibrosis, and fibrinolysis. We foun...
Predicted journal destinations
1
European Respiratory Journal
44 training papers
2
American Journal of Respiratory and Critical Care Medicine
23 training papers
3
JCI Insight
63 training papers
4
ERJ Open Research
36 training papers
5
BMJ Open Respiratory Research
32 training papers
6
Thorax
29 training papers
7
Nature Communications
483 training papers
8
Scientific Reports
701 training papers
9
Frontiers in Immunology
140 training papers
10
PLOS ONE
1737 training papers
11
iScience
74 training papers
12
Journal of Allergy and Clinical Immunology
15 training papers
13
EBioMedicine
21 training papers
14
eLife
262 training papers
15
PLOS Pathogens
35 training papers
16
Science Translational Medicine
40 training papers
17
Proceedings of the National Academy of Sciences
100 training papers
18
The Lancet Respiratory Medicine
16 training papers